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RISK FACTORS FOR DELAYED DIAGNOSIS OF SUBARACHNOID AND 
INTRACEREBRAL HEMORRHAGE. Joyce M. Oen-Hsiao, Catherine M. Viscoli, and Walter N. 
Kernan. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT. 
 
To identify risk factors for delayed diagnosis of subarachnoid (SAH) or intracerebral (ICH) 
hemorrhage in younger patients (ages 18 – 49), we performed a subsidiary case-control study 
among 702 subjects from the Hemorrhagic Stroke Project (HSP).  Case subjects were the 54 HSP 
patients (7.7%) who did not receive an appropriate diagnostic evaluation (brain CT scan, and if CT 
negative, LP) within 24 hours of consulting a physician for symptoms consistent with hemorrhagic 
stroke.  For each case subject with a delayed diagnosis, we identified two subjects from the HSP 
with a prompt diagnosis, all successfully matched on recruitment site.  We calculated odds ratios 
(ORs) for the association between risk factors and delayed diagnosis. 
Four features were associated with risk for delayed diagnosis (criteria: OR =2.0 or =0.5): 
initial evaluation in a physician’s office (OR=23.1), absence of alarm symptoms (photophobia, loss 
of consciousness, focal weakness) (OR=4.6), no effortful activity preceding focal time (OR=5.5), 
and Hispanic ethnicity (OR=2.4).  Risk factors associated with delayed diagnosis were different in 
patients who presented to the hospital compared to patients who presented to an office.  In a 
separate analysis, risk factors associated with delayed diagnosis were different for patients with 
SAH compared with patients with ICH. 
In conclusion, patients with SAH or ICH are at greater risk for a delay in their diagnosis if 
they do not have alarm symptoms, especially if they present to an office rather than a hospital 
emergency department.  Efforts to reduce delayed diagnosis should be directed at primary care 
physicians who see low-risk patients with milder symptoms.  Our findings also indicate that there 
are different risk factors associated with delayed diagnosis of hemorrhagic stroke based on location 
of presentation and on stroke type.  Future research to understand and prevent delayed diagnosis 
must consider location of presentation and stroke type.
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INTRODUCTION 
I. Overview 
 
Intracranial hemorrhage, including subarachnoid hemorrhage (SAH) and 
intracerebral hemorrhage (ICH), affects approximately 102,000 persons in the United 
States each year. SAH will be diagnosed in approximately 60,000 persons and ICH will 
be diagnosed in 42,000 persons. (1) SAH carries a mortality rate of approximately 55% in 
the first two months after initial bleed (2, 3), whereas ICH has a mortality rate between 
35-52% in the first 30 days. (4-6) Of those who survive either SAH or ICH, the majority 
will be left with long-term disability. 
A major advance in management of patients with intracranial hemorrhage has 
been the finding that early treatment improves outcome for patients with SAH.  Studies 
by Kassell, et al. demonstrated that poor outcome was closely associated with vasospasm 
and re-bleeding and that the period of higher risk for re-bleeding was during the first 
three days after the initial event.(7, 8) 
Early institution of therapy after SAH is associated with reduced risk of re-
bleeding and improved functional outcome. (9, 10) Unfortunately, approximately 20% of 
patients experience a delay in diagnosis on their initial presentation and, thus, experience 
a delay in care.  Although there have been many studies examining the effect of delayed 
diagnosis, the frequency and reasons for delay in diagnosis are currently not well known. 
While early institution of therapy of SAH has been studied, early institution of therapy 
for ICH is not well documented.  Although early therapy is not documented for ICH, 
neurosurgeons believe in the importance of early diagnosis for ICH. (6) 
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The purpose of our study, therefore, is to examine the risk factors for delayed 
diagnosis of intracranial hemorrhage in both the hospital and the outpatient office 
settings. 
 
II. Epidemiology 
II.1 Subarachnoid Hemorrhage 
 
Subarachnoid hemorrhage results when a blood vessel on the surface of the brain 
ruptures and bleeds into the space between the brain and the arachnoid.  Usually, the 
vessel ruptures at a weakened area caused by an aneurysm, or dilatation, on a blood 
vessel (usually an artery).  The most common type of aneurysm is a saccular protrusion 
attached to the artery by a small neck. 
The incidence of SAH in North America is approximately 11-12 per 100,000. (1) 
Risk factors associated with risk of SAH include age, race, and gender.  The incidence is 
greater in older people compared with younger people.  The average age of onset of SAH 
is around 51 years, with most cases occurring in people over the age of 30.  Although 
race is not associated with a difference in the incidence for aneurysm, it has been shown 
that certain populations in Japan and Finland have a higher rate of SAH from aneurysms. 
(2) The frequency of aneurysmal SAH in different countries most likely reflects the 
differences in population characteristics in those countries.  In Cincinnati, a retrospective 
cohort study was conducted to determine whether there was a difference in the risk of 
ICH or SAH in African-Americans versus Caucasians. (11) Medical records, autopsy 
reports, and CT scans of all patients who were suspected of having an ICH or SAH 
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during the year were reviewed.  When considering all age groups, there was a higher 
incidence of both SAH and ICH in blacks when compared to whites.  Blacks had 2.1 
times the risk of SAH of whites. (11) The problem with this study was that subjects were 
identified solely by the ICD-9-CM codes for ICH, SAH, cerebral aneurysm, 
arteriovenous malformation, and cerebrovascular accident.  Patients were not actively 
identified on initial presentation to the hospital. 
Aneurysms usually occur more frequently in men than women (4:1) up until the 
fifth decade of life.  The prevalence of aneurysms is equal in men and women around the 
fifth decade.  By the eighth decade, women have more aneurysms than men do (10:1). (2) 
Gender also appears to play a role in location of aneurysms.  The proximal internal 
carotid is the site of more aneurysms in women, whereas the anterior communicating 
region is the more prevalent site in men. (2) Demographic characteristics are not the only 
factors that result in an increased risk of SAH.  Clinical risk factors that lead to an 
increased risk of SAH include prevalence of hypertension or atherosclerosis and diet, 
tobacco, and alcohol habits. 
Among all patients with a SAH, the mortality rate at one month is 45%, but most 
deaths occur in the first few days. (12) The leading causes of death are acute, effects from 
the initial hemorrhage, recurrent hemorrhage, and cerebral vasospasm (leading to 
rebleeding or ischemic brain damage, and infarction).  The volume of blood after a SAH, 
calculated by CT scan, was significantly related to 30-day mortality. (12) The effects of 
the initial hemorrhage are related to mortality.  Patients with a worse neurological 
outcome after their SAH tend to have a higher rate of mortality.  The poorer the 
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neurological condition of the patient and the more blood present on the initial CT scan, 
the greater the likelihood of rebleeding. 
Rebleeding is defined as recurrent hemorrhage due to inadequate hemostasis or 
arterial vasospasm, causing a clinical decline in a patient after a SAH.  In the first few 
hours after SAH, up to 15% will re-bleed and up to 23 % will re-bleed within the first 
two weeks. (10, 13-15) These first few hours appear to be the most common time for 
rebleeding to occur, and early management is necessary to avoid risk of rebleeding. (12, 
14) Mortality due to rebleeding has been reported to range from 50% to 80%. (10, 14) 
Medical treatments to control vasospasm and early surgical interventions effectively 
eliminate risk of rebleeding. (16) 
Re-bleeding after a SAH event was studied by Hillman, et al. (17) Approximately 
95% of patients hospitalized within 24 hours of symptom onset and 50% of patients 
hospitalized within 6 hours of SAH were studied.  60% of deaths were attributed to the 
initial bleeding episode, although 10% of patients admitted within 24 hours suffered from 
early rebleeding.  Of the rebleeding patients, 82% died and 9% had a poor outcome.  
Most of the rebleeding occurred within the first 24 hours. (17) This finding is consistent 
with other investigations on re-bleeding after SAH. (12, 14, 18) In all studies, the peak 
incidence of rebleeding occurred within the first 24 hours after the initial hemorrhage, 
with a mortality rate between 74 – 85%. 
The typical patient with SAH seeks care after the sudden onset of a severe 
headache often associated with loss of consciousness, focal neurological deficits, and 
nuchal rigidity.  The headache is usually continuous.  Initially the headache is focal, but 
then generalizes as time passes. 
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About 8% to 10% of patients present with atypical symptoms, such as back pain, 
nausea, lethargy, and eye or facial pain, and a more gradual evolution symptoms. (19, 20) 
Table A lists the symptoms of 41 patients who had a delay in diagnosis of SAH after 
presentation to a physician. (21) Adams et al. (21) concluded that the presence of atypical 
symptoms led physicians to consider an alternate diagnosis than SAH.  Other symptoms 
that have been identified in patients with SAH include acute chest pain, proctalgia, 
paraplegia, and leg pain.  Patients can often present as confused, irritable, uncooperative, 
and can sometimes exhibit combative behavior.  These atypical symptoms, which were 
determined to be those symptoms with a prevalence < 25%, may distract attention from 
the bleed by impeding examination by the physician. 
Diagnosis of SAH is made when blood is seen in the subarachnoid space either by 
CT scan, angiography, lumbar puncture (LP) or at autopsy.  Strategies for diagnosis of 
SAH include a brain CT scan.  However, in 3-4% of cases, the CT scan is normal. (22, 
23) When a patient has a clinical syndrome consistent with SAH and a normal brain CT, 
current guidelines recommend that physicians perform an LP to test for red blood cells 
and xanthrochromasia in the CSF. (1) Xanthrochromia is a yellowish discoloration of the 
CSF supernatant when the CSF is centrifuged that is a result of degradation of red blood 
cells in the subarachnoid space.  The disintegration of erythrocytes releases 
oxyhemoglobin into the CSF, which is then converted into bilirubin.  Because there exists 
a risk of deterioration after LP due to herniation in patients with suspected SAH, a CT 
scan and a neurological examination should be performed before the LP is done. 
Poor outcome of patients affected by SAH are most closely related to three 
baseline variables: 1) neurological condition of the patient on admission 2) volume and 
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location of initial bleed and 3) patient’s age and compliance of the brain parenchyma. 
(21-22) Of these three prognosticators, the neurological condition, particularly the level 
of consciousness, is the most important determinant. (18) Prognosis of patients with SAH 
can be estimated based on a clinical grading system called the Hunt and Hess Scale, 
shown in Table B. 
Prognosis can also be correlated to the Glasgow Coma Scale (GCS), shown in 
Table C.  The Glasgow Coma Scale is the most widely used scoring system used in 
quantifying level of consciousness following traumatic brain injury.  A lower GCS score 
usually leads to higher mortality.  On initial presentation after the brain injury, the best 
eye opening response, the best verbal response, and the best motor response are 
determined.  The score (E+V+M) represents the sum of the numeric scores of each of the 
categories. 
The presence of other factors, such as hypertension and smoking or alcohol 
history also decreases chance for survival.  Location of aneurysm also affects the 
prognosis, with posterior circulation aneurysms having a higher mortality rate. 
 
II.2 Intracerebral Hemorrhage 
 
Intracerebral Hemorrhage refers to bleeding into brain tissue, not from 
subarachnoid hemorrhage.  The incidence of ICH in North America is approximately 4-6 
per 100,000 persons per year. (1) The incidence of ICH is low among persons below the 
age of 45 years and increases dramatically from age of 65 years.  After the age of 75 
years of age, the incidence of ICH plateaus or decreases, due to reasons which are not 
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clear, but are speculated to be due to other diseases causing mortality before ICH can 
manifest itself.  ICH also tends to occur more frequently in men, the difference most 
likely because of presence of established risk factors for ICH. (6) 
Race and ethnicity are important determinant of the risk for ICH.  Asians, in 
particular the Japanese, have a 2-3 times increased risk for ICH compared with other 
countries. (6) In the United States, the risk of ICH is increased 2-3 fold in African-
Americans compared with Caucasians. (11) Under the age of 75 years, blacks had a 2.3 
times greater risk of ICH than whites.  This may be attributed to the increased incidence 
of hypertension among African-Americans. (11) Other clinical risk factors for ICH 
include diagnosis of hypertension, excessive alcohol consumption, anticoagulants, drug 
use, and hypocholesterolemia. 
Patients with ICH typically present with sudden onset of severe headache, 
vomiting, depressed consciousness, and focal neurologic signs.  Other symptoms include 
seizures and nausea.  There can be a progressive worsening of symptoms after the initial 
abrupt headache.  ICH frequently occurs during the day, with a peak in the morning just 
after awakening.  Hemorrhage is usually associated with activity.  Symptoms associated 
with ICH can vary with intensity and location of the bleed.  Severe headache is reported 
in only 30-40% of cases.  One-third of patients with ICH do not report any headache. (6) 
Although most cases of ICH have been attributed to hypertension, there is an increasing 
number cases in patients for whom there has not been a diagnosis of hypertension.  ICH 
in these patients may be associated with non-hypertensive mechanisms that include 
aneurysms, tumor, vascular malformations, vasculopathies, and disorders of coagulation.  
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Diagnosis of ICH is typically made when blood is seen within the brain parenchyma on 
CT scan or MRI. 
Prognosis after ICH is largely dependent on location of the lesion.  The most 
common location of ICH is within the putamen (40%). (6) The clinical spectrum of 
putaminal hemorrhage ranges from small, asymptomatic lesions to large fatal lesions.  
Mortality from putaminal hemorrhage ranges between 20-40%.  Thalamic hemorrhage 
accounts for 10-15% of ICH.  Mortality rates have varied based on previous studies, but 
there appears to be a direct correlation between size of the hemorrhage and mortality.  
Caudate hemorrhage accounts for 5-7% of all ICH, and prognosis is generally good for 
patients, with most experiencing complete recovery.  Pontine hemorrhage accounts for 
approximately 5% of all ICH, and when the hemorrhage involves the paramedian area 
bilaterally, the hemorrhage is usually fatal.  Those who survive are neurologically 
devastated.  Smaller pontine hemorrhages found in the basis pontis usually carry an 
excellent prognosis.  Cerebellar hemorrhage of the hemispheres accounts for 10% of 
ICH, with a mortality rate of approximately 30%.  Prognosis depends on level of clinical 
function, especially level of consciousness, after the acute event. 
Long-term outcome after ICH was related to the acute hemorrhage.  Case-fatality 
from ICH is approximately 35% to 52%. (4, 5) Mortality rates for ICH range from 20% 
to 40%, although the mortality in Asian countries appears to be 2 to 3 times greater than 
in Western countries. (6) Among those who survive 30 days, 50% to 70% have an 
excellent recovery and are able to function independently 6 months to a year after the 
acute hemorrhage. (6) Large hemorrhage size, ventricular hemorrhage, and older age are 
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associated with increased risk for poor functional recovery.  Recurrent hemorrhage is 
rarely seen after ICH, except in hemorrhages that were not related to hypertension. 
SAH and ICH are very different entities with regards to risk factors, 
pathophysiology, and initial clinical presentation.  Therefore, to examine hemorrhagic 
stroke as one entity including both SAH and ICH may not necessarily be an effective 
analysis.  In order to determine whether risk factors for delayed diagnosis of hemorrhagic 
stroke will be consistent for both SAH and ICH, risk factors need to be studied for each 
hemorrhagic stroke type separately. 
 
III. Importance of Early Diagnosis 
 
Early diagnosis of both SAH and ICH is necessary to improve outcome in 
survivors of the hemorrhage.  By recognizing hemorrhage at its initial presentation, many 
treatment options are available for the patients, from medical to surgical treatments.  
However, after the first 2-3 days post-bleed, treatment options are limited, and brain 
damage from inflammation or from the hemorrhage cannot be reversed. (16)  
 
The optimal time for aneurysm surgery was studied in the International 
Cooperative Study on the Timing of Aneurysm Surgery. (7, 8) A prospective, 
observational clinical trial was conducted to determine the best time in relation to the 
hemorrhage for surgical treatment of ruptured intracranial aneurysms. 3521 patients 
hospitalized within three days of SAH were enrolled from sixty-eight centers.  Patients 
were grouped into prespecified "planned" surgery intervals.  The day of the SAH event 
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was defined as day=0.  The planned surgery intervals were determined by the 
neurosurgeon as soon as the diagnosis of SAH was made.  Outcome rates consisted of 
those patients whose surgery was planned but who were not operated on in addition to 
those patients who actually had surgery.  If a patient was admitted on Day 2 and had 
surgery planned for between Days 7 and 10 but rebled and die on Day 6, mortality was 
attributed to planned surgery of interval Days 7 to 10. If a patients was scheduled to have 
surgery between Days 7 and 10 but deteriorated on Day 6, then recovered to have surgery 
with a favorable outcome on Day 12, this good result would be credited to planned 
surgery interval Days 7 to 10.  The postoperative risk following early surgery is 
equivalent to the risk of rebleeding and vasospasm in patients waiting for delayed 
surgery.   Analysis of these prespecified intervals demonstrated that there was no 
difference in early (0 to 3 days after the bleed) or late surgery (11 to 14 days). Outcome 
was worse if surgery was performed in the 7 to 10-day post-bleed interval. Surgical 
results were better for patients operated on after 10 days. Overall, early surgery was 
neither more hazardous nor beneficial than delayed surgery.  Although 24% of patients 
originally scheduled for surgery at 11-14 days and 38% of patients originally scheduled 
for surgery at 15+ days, results could still be made to determine the best length of time 
post-SAH that surgery should be performed.  Outcomes of patients who had surgery 
within three days of SAH were optimal, with 60% of the patients having a good outcome 
and few neurological deficits. (7, 8)  
Other studies have also shown that early diagnosis and early institution of therapy 
of SAH improves functional outcome and decreases morbidity among patients with SAH. 
(24-26) However, it also has been documented in multiple studies that recognition of the 
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SAH is very difficult.  In a study on minor leak and outcome in patients whose diagnosis 
was either prompt or delayed, mortality for those patients who had a recognized minor 
leak that was treated before a major rupture (0%) was much better than for those patients 
whose minor leak was not identified (52%). (24) 
There is a need for prompt recognition of SAH because some patients with a 
ruptured aneurysm will rebleed within the first two weeks after the SAH.  Despite the 
evidence that early therapy improves outcome, the average interval between onset of 
symptoms of intracranial hemorrhage and diagnosis is approximately 5-11 days and 18% 
of patients do not seek care for > 24 hours. (27) Previous reports of SAH indicate that for 
13-50% of patients, diagnosis is significantly delayed. (20-23, 27, 28)  The studies on 
delayed diagnosis of SAH were able to identify presenting symptoms of those patients 
with a delayed diagnosis, however none were able to determine specific risk factors that 
led to the delay. 
 
IV. Delayed Diagnosis of Hemorrhagic Stroke 
 
There are 10 prior cross-sectional studies that were done to determine outcome of 
delayed diagnosis of SAH, shown in Table D.  Only one (Kassell, et al., 1985) (20) also 
investigated delayed diagnosis of ICH.  There are five studies of delayed diagnosis that 
will be discussed, in addition to a recent review of some prior studies of delayed 
diagnosis of SAH. 
Adams et al. (21) performed a cross-sectional study by reviewing charts of 182 
patients admitted to the University of Iowa Hospital for SAH secondary to ruptured 
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aneurysms.  All cases of SAH were confirmed by CSF examination, angiography, 
operation, or autopsy.  Although delayed diagnosis was never defined, the assumption is 
that the patients with a delayed diagnosis were those patients who received a diagnosis 
different from SAH upon presentation to a physician with their symptoms.  Of the 182 
patients admitted, 41 (23%) had a delay ranging from one to twenty-seven days in the 
diagnosis of SAH.  However, upon reviewing the patient’s history and chart, Adams 
noted that not all of the misdiagnosed cases were of atypical presentation or mild 
symptoms.  Headache was the chief complaint in 33 of the 41 patients (80%) in the 
patients with delayed diagnosis.  In fact, the 41 patients had a delay in diagnosis of SAH 
even though headache, vomiting, and loss of consciousness were the common presenting 
symptoms.  The delay was attributed to local physicians making an alternate diagnosis, 
although the delay by the hospital staff in the emergency department did not appear to be 
included in the study. 
Adams et al. (21) nicely summarizes what symptoms each patient had at the time 
of initial presentation for the SAH.  The alternate diagnoses were noted and reasons were 
discussed as to why the alternate diagnoses were given.  Infectious illness was the 
diagnosis given to patients who presented with fever, malaise, nausea, vomiting, and 
headache without evidence of focal neurological signs.  Migraine and sinusitis were other 
common diagnoses.  Patients with severe neck pain and headache were diagnosed with 
cervical disk herniation or neck strain.  Based on the results of the chart review, Adams et 
al. concluded that a more careful search for SAH should be done in patients who present 
with atypical symptoms.  Also, he reiterated that prompt investigation with CT scan 
and/or lumbar puncture to look for xanthrochromasia is the most useful diagnostic 
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procedures to evaluate intracranial hemorrhage.  This study is a concise look at the 
symptoms of SAH on initial diagnosis, even recording the atypical symptoms seen.  
However, the analysis of symptoms did not go beyond determining symptoms.  No 
analysis was done to see whether a certain symptom was a risk factor for the delayed 
diagnosis of SAH. 
In 1985, Kassell et al. (20) reviewed medical records for all hospitalized patients 
during July 1977 and July 1983 with a discharge diagnosis of SAH at the University of 
Iowa to determine the length and cause of delayed referral.  Physicians referred only 36% 
of the patients to the Acute Stroke Care and Monitoring Unit within 48 hours of clear cut, 
recognizable signs or symptoms of SAH.  The definition of the clear and recognizable 
signs and symptoms of SAH was not given.  Most patients were referred to the 
neurosurgical stroke service several days after onset of SAH, which was detrimental to 
patient care and contributed to greater morbidity and mortality. 
Delays were broken down into 6 categories: physicians’ diagnostic problems, 
which was defined as failure of physicians to make or suspect a diagnosis of SAH (37%); 
delayed referral policy, defined as a decision by the referring physician to delay transfer 
of the patient until the neurological status had improved or until an arbitrary number of 
days had passed (23%); logistics, defined as delays due to scheduling or completion of 
diagnostic tests (CT or angiography), initiation of treatment, or arrangements for 
transportation (12%); failure of patients to seek medical attention (8%), unstable 
condition (7%), or other (13%).  The more common causes for delayed diagnosis were 
due to physician failure to recognize the diagnosis and delays in referral policies.  These  
both were thought to be avoidable causes for delay.  Kassell et al. (20) therefore 
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concluded that public health and primary physician education was necessary to reduce the 
number of patients with delayed neurosurgical care.   The problem with this study is that 
it only included patients who were transferred to the neurosurgical acute stroke unit from 
outside the hospital.  It never mentioned patients who were seen at the emergency room.  
Also, only SAH was studied at this time. 
Schievink et al. at the University of Amsterdam (27) conducted a cross-sectional 
retrospective chart review of 334 patients admitted to the neurosurgical unit between 
August 1979 and January 1987 with SAH due to aneurysmal rupture confirmed by LP, 
CT, operation, angiography, or autopsy.  Causes of delayed diagnosis were divided into 
three categories used by Kassell et al. (20), which included patient delay, delay from 
misdiagnosis, and hospital delay.  Patients who presented to the hospital in bad clinical 
condition were more promptly referred to the neurosurgery department compared to those 
patients in good clinical condition.  There was a delay in referral to the neurosurgery unit 
in164 of 334 (49%) patients with SAH.  Of those patients whose referral was delayed, 
failure of patients to seek medical attention caused delay in 29 (18%) patients.  
Physicians’ diagnostic errors were responsible for delay in 95 (58%) patients.  A delay at 
the referring hospital occurred in 97 (59%) patients.  The delay caused by physician 
diagnostic errors averaged 10.5 days.  In more than 40% of the cases, patient delay in 
seeking medical attention was followed by a phys ician’s diagnostic error.  This was 
attributed to the less severe symptoms found in these patients. 
Schievink (27) concluded that physicians were unfamiliar with SAH and that this 
is the cause for the large number of incorrect diagnoses.  He attributes this to the fact that 
an average general practitioner would only see aneurysmal SAH once every 3 – 4 years.  
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It was concluded that educating the public, medical students and physicians about the 
signs and symptoms of SAH and the importance of prompt therapy to improve overall 
outcome should help to decrease the number of incorrect diagnoses of SAH.  Although 
this study was a good evaluation of causes for delayed diagnosis in a large population, 
because of the specialized neurosurgical center, the study included an overrepresentation 
of posterior circulation aneurysms.  Also, it was not defined whether the patients were 
referred from physicians’ offices or from the emergency room. 
In his study of SAH in the emergency department, Fontanarosa (23) found that 16 
of 109 patients (15%) had a delayed diagnosis.  These patients presented to physicians 
with headache, but an otherwise normal neurologic exam.  The patients did not present 
with neck stiffness and the headache typically had lasted a couple of days.  Of note, none 
of the 16 patients who were incorrectly diagnosed had a lumbar puncture performed. 
To study prevalence and outcome of patients with cerebral aneurysm who were 
misdiagnosed on initial medical presentation, Mayer et al. (22) conducted a retrospective 
chart review of 217 patients.  Patients were studied in four tertiary-care neurosurgical 
centers.  Misdiagnosis was said to have occurred if the initial medical evaluation did not 
consider the possibility of intracranial aneurysm or if the diagnosis of aneurysm was 
delayed by more than 24 hours from the time of presentation to medical attention with 
symptoms consistent with intracranial aneurysm.  Of the 217 patients in the study, 54 
patients (25%) with cerebral aneurysms were misdiagnosed on first presentation to a 
healthcare professional for symptoms or signs of cerebral aneurysm and were initially 
misdiagnosed.  This misdiagnosis was associated with worse clinical outcome. 
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Most of the patients who were misdiagnosed were patients in good clinical 
condition whose course were more likely to deteriorate clinically.  Patients were followed 
based on rebleed and deterioration.  Patients were clinically graded on initial presentation 
using a modified Hunt and Hess grading scale.  Grade was established based on best 
condition achieved within the first 24 hours after initial medical presentation: Grade 1: 
headache and seizure only; Grade 2: any meningeal symptoms and signs; isolated cranial 
nerve palsy, nausea, or vomiting; Grade 3: altered level of consciousness; Grade 4: coma; 
Grade 5: coma plus hemodynamic instability.  Rates of misdiagnosis were determined for 
each clinical grade.  For patients with symptoms of grades 1 or 2, 46 of 121 patients 
(38%) were misdiagnosed on initial presentation.  For patients with altered levels of 
consciousness, 6 of 56 patients (11%) were misdiagnosed on initial presentation.  For 
grades 4 and 5, 2 of 40 patients (5%) who were unconscious were misdiagnosed initially. 
In evaluating the outcome of patients, twenty-six of 54 misdiagnosed patients 
(48%) rebled or deteriorated after initial presentation to medical attention before correct 
diagnosis and management was given.  This was compared to only 4 out of the 163 (2%) 
correctly diagnosed patients.  This difference was statistically significant.  In addition, for 
patients with clinical grades 1 or 2, 68 of 75 (91%) of patients who were correctly 
diagnosed had an excellent/good outcome compared with 24 of 45 (53%) of patients who 
were initially misdiagnosed.  Studying poor outcome or death in patients with clinical 
grades 1 or 2, 3 of 75  (4%) of patients with correct diagnosis had poor outcome 
compared with 16 of 45 (36%) of patients with misdiagnosis.  Even though this study was 
not designed to identify risk factors for misdiagnosis, the authors reported that most 
missed cases occurred because physicians did not consider the diagnosis of SAH (and 
 17 
 
order a CT scan or a lumbar puncture) in the differential diagnosis of patients’ 
complaints. 
Ferro et al. (28) looked at the causes of delayed diagnosis and referral of patients 
with SAH.  A prospective study was conducted of 112 patients who presented to the 
departments of neurology and neurosurgery in Portugal from January 1985 to December 
1987 with SAH confirmed by CT scan and/or LP or angiography.  Demographic and 
clinical data was recorded on admission.  The causes of delayed referral were split into 
categories originally used by Kassell et al.(20), including failure of the patient to seek 
medical treatment, physicians’ diagnostic error, and delayed transfer policy. 
This study found that the main cause of delayed referral to the neurology or 
neurosurgery departments was physician inability to diagnose SAH in the 39 (70%) 
patients with symptoms consistent with SAH.  This study did recognize that delay due to 
physician failure to consider the diagnosis does not only occur in private physician 
offices.  Many times, the diagnostic error can occur in the emergency room, and, in fact, 
13% of the patients with delayed admission in this study were misdiagnosed in an 
emergency room setting.  The primary physician correctly diagnosed twenty-three 
percent of the patients with a delay in admission, but there was a delay in transfer of the 
patient to the hospital in time for treatment.  Patients’ age or sex, presence or severity of 
headache, history of hypertension, blood pressure at onset, or initial symptoms (loss of 
consciousness, focal symptoms) were not factors that led to early diagnosis or referral.  
Instead, early diagnosis and referral were strongly influenced by the severity of the 
clinical picture.  The main factor leading to physician delayed referral was mild clinical 
symptoms on presentation.  The severity of the initial hemorrhage also correlated with the 
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length of delay in referral.  The authors concluded that improving diagnostic referral is 
dependent on physicians’ education rather than public education. 
The remaining cross-sectional studies about delayed diagnosis of SAH were able 
to identify symptoms and outcome of delayed diagnosis of SAH, with results resembling 
those previously described. 
Edlow et al. (29) reviewed various studies regarding misdiagnosis of 
subarachnoid hemorrhage and came to three conclusions: 1) physicians consistently 
misdiagnose SAH; 2) the patients with the greatest likelihood of benefiting from surgery 
are the ones who most often receive an incorrect diagnosis; 3) early complications 
develop in patients with an incorrect diagnosis, resulting in worse outcomes in these 
patients than in those initially given a correct diagnosis.  Many patients with SAH present 
with findings that deviate from the classic presentation.  Patients with atypical symptoms 
can present with SAH during nonstrenuous activity or sleep.  The headache they suffer 
may present in any location.  Alternatively, headache may not be present at all, with the 
patient’s discomfort only evidenced by neck pain.  Edlow’s review of the literature 
concluded that most warning headaches are indications of unrecognized subarachnoid 
hemorrhages that can be diagnosed by appropriate methods.  In addition, properly 
performed and interpreted CT and lumbar puncture in patients with acute, severe 
headache will best identify the majority of patients with SAH. 
A common conclusion of the prior studies was that physician education would 
help physicians to keep hemorrhagic stroke in mind so that they will be able to promptly 
identify the diagnosis and refer patients to neurosurgical centers so that early intervention 
can be implemented.  A study of whether an educational program for primary care 
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physicians would reduce misdiagnosis or delayed diagnosis of SAH was conducted in 
Sweden. (30) Both the local city population and the nine surrounding community 
hospitals use the same neurosurgical center.  Fridriksson et al. (30) instituted a teaching 
program in the physicians’ offices in the local city population that usually refer their 
neurosurgical patients to the center.  Teaching focused on recognizing the most common 
clinical presentation of sudden onset of headache as a sign of SAH.  In addition, 
maintaining individual follow-up of all referred cases opened communication between 
the community physician and the neurosurgeon.  No extra contact was made with the 
remaining community hospitals.  Outcome of patients was evaluated at 6 months after 
SAH.  A good outcome was defined as patients without neurological deficits (except 
isolated cranial nerve palsy) returning to their premorbid activities.  The educated 
population had 35 cases of ruptured aneurysms with only 1 patient (3%) having a delay in 
referral by the local city physician.  However, in the remaining population that was not 
given the teaching program, 4 of 152 (3%) patients had a delayed referral and 14 of 152 
patients (9%) had a misdiagnosis of warning episodes.  Therefore, the total of 18 of 152 
patients (12%) had some form of delayed referral of their ruptured aneurysm.  
Conclusions were that the focused attention to sudden onset headache through the 
teaching program alerted local physicians to diagnose SAH at the first hemorrhagic event 
in a higher percentage than average.  Therefore, fewer individuals had a misdiagnosis of 
their hemorrhagic stroke on transfer to the neurosurgical center.  Based on these results, 
one could argue that identifying the risk factors for delayed diagnosis of hemorrhagic 
stroke and incorporating them into a teaching program for physicians may be beneficial 
to reduce delay. 
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In summary, previous cross-sectional studies have studied the effects of delayed 
diagnosis of SAH.  In Iowa, Adams et al. (21) reviewed the charts of 182 patients with 
SAH secondary to ruptured aneurysms and noticed that 41 patients had a delayed 
diagnosis.  Adams identified the symptoms of the 41 patients with a delayed diagnosis, 
however he did not analyze whether the atypical symptoms were a risk for delayed 
diagnosis.  Kassell et al. (20) reviewed medical records for all hospitalized patients with a 
SAH to determine the length and cause of delayed referral.  It was determined that 
physician failure to recognize the diagnosis was the most common cause for delayed 
diagnosis.  In Amsterdam, Schievink et al. (27) conducted a chart review of 334 patients 
admitted to a neurosurgical unit with SAH and noticed that there was a delay in referral 
of 164 patients.  Physician’s diagnostic error was the most common cause for delay in 
58% of the patients, and it was concluded that the incorrect diagnoses were most likely 
the result of physicians being unfamiliar with SAH.  Mayer et al. (22) conducted a chart 
review of 217 patients with cerebral aneurysm to determine the prevalence and outcome 
of patients with cerebral aneurysm who were misdiagnosed on initial medical 
presentation.  54 of the 217 patients were cerebral aneurysms were misdiagnosed on first 
presentation to a healthcare, and the delay in care of these patients was associated with a 
worse outcome.  Ferro et al. (28) studied the causes of delayed diagnosis and referral of 
patients with SAH.  Physician inability to recognize the diagnosis was the most common 
cause of delayed referral in 39 of the 112 patients.  In all of these studies, delayed 
diagnosis was recognized to lead to worse outcome, but no analysis of symptoms 
associated with delayed diagnosis was performed. 
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The problem of delayed diagnosis is most commonly due to physicians failing to 
consider the diagnosis of hemorrhagic stroke.  There has not yet been a study adequately 
designed to examine the full spectrum of risk factors for delayed diagnosis and thus 
determine the features that are associated with a delayed diagnosis.  Additionally, there 
have been many studies with regards to delayed diagnosis of SAH, but few have 
examined delayed diagnosis of ICH.  Finally, there has not yet been a study to compare 
delay of diagnosis in the emergency room setting versus a physicians’ office or telephone 
consult. 
 
STATEMENT OF PURPOSE AND HYPOTHESIS 
 
The purpose of this study is to identify the risk factors associated with delayed 
diagnosis of non-traumatic intracranial hemorrhage.  We hypothesize that symptom 
characteristics, site of care, headache history, and demographic variables may affect risk 
for delayed diagnosis.  The study will also identify if there is a difference between 
delayed diagnosis of SAH and ICH based on the risk factors.  Finally, risk factors for 
delayed diagnosis will be evaluated to determine if there is a difference based on location 
of initial contact.  The results of this study will be useful to establish guidelines for 
recognizing subarachnoid and intracerebral hemorrhage to aid physicians in early 
recognition of hemorrhage, thus decreasing morbidity and mortality. 
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RESEARCH METHODS 
 
Overview 
This study is designed as a subsidiary case-control study within a larger case-
control study of the causes of hemorrhagic stroke in young persons, the Hemorrhagic 
Stroke Project (HSP). (Figure 1) 
 
Hemorrhagic Stroke Project (HSP) 
HSP Selection of Cases 
 
Between December 1994 and July 1999, case subjects with hemorrhagic stroke 
were recruited from hospitals located in Connecticut, Southern Massachusetts, Southern 
Ohio, Northern Kentucky, Rhode Island, and Texas.  Active surveillance of all 
admissions at each of the participating hospitals identified patients with hemorrhagic 
stroke.  Surveillance involved review of admission rosters and direct monitoring of 
admissions by one or more designated individuals, such as a discharge planner or stroke 
nurse.  In order to check completeness of case identification, discharge rosters were 
reviewed from each participating hospital during the mentioned time period. 
Eligibility criteria for case subjects included admission to a participating hospital, 
age between 18 and 49 years (inclusive), symptomatic primary subarachnoid hemorrhage 
(SAH) or primary intracerebral hemorrhage (ICH), and ability to participate in a direct 
interview within 30 days of the stroke event.  Patients with other diagnoses, including 
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subdural hematomas and hemorrhages associated with ischemic infarcts, trauma, 
thrombolytic therapy, or cerebral vein thrombosis were not eligible for this study. 
Diagnosis of SAH was based on the presence of a high intensity signa l in the 
subarachnoid space by computed tomography (CT) or by lumbar puncture (LP) showing 
xanthochromasia not explained by other etiologies (e.g. liver disease, increased CSF 
protein, hypervitaminosis A).  An ICH was diagnosed by a CT scan showing a 
hyperintense signal within brain parenchyma.  If other studies were not diagnostic and 
after consultation with a neuroradiologist, magnetic resonance imaging (MRI) was 
accepted for the diagnosis of SAH or ICH.  Exclusion criteria included prior stroke and 
brain lesion predisposing to hemorrhage risk (e.g. arteriovenous malformation, vascular 
aneurysm, or tumor) known to exist prior to the index event.  Patients were also excluded 
if they first experienced stroke symptoms after being in the hospital for 72 hours for an 
unrelated matter. 
The treating physician gave permission to contact each potential case subject.  
Once permission was received, a researcher met with the patient and reviewed pertinent 
data to confirm eligibility.  Eligible patients were invited to participate and give verbal 
informed consent.  During the consent procedure, all subjects (cases and controls) were 
told that the study was designed to examine causes of hemorrhagic stroke in young 
persons without specific mention of potential risk factors.  Case subjects who did not 
speak English were interviewed using a translator who, with rare exception, was not a 
relative or acquaintance.  Most interviews were conducted in the hospital, but some were 
completed at home and three were complete by telephone. 
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HSP Selection of Controls 
 
Two matched control subjects were identified for each case subject.  Matching 
criteria included: gender, ethnic group (African-American versus non-African-
American), and age (within 3 years for case subjects less than 30 years and within 5 years 
for cases 30 years of over).  All control subject interviews had to be completed within 30 
days of the case’s stroke event to minimize seasonal differences in the likelihood of 
exposure to cough/cold remedies.  A computer-generated list of random telephone 
numbers (matching the first three digits of the case subject telephone number) was used 
to identify potential control subjects.  Eligibility criteria for control subjects were the 
same as for case subjects except for those criteria related to the stroke event.  Once an 
appropriate control subject was identified, he or she was invited to participate.  The 
interview was then conducted in person in the control subject’s home, a doctor’s office, 
or by telephone.  Control subjects who traveled long distances for the interviews were 
offered twenty dollars to defray the cost of their expenses. 
 
HSP Specification of Focal Time  
 
Each case subject was assigned a focal time.  The focal time was defined as the 
calendar day (i.e. index day) and time of day that marked the onset of symptoms 
plausibly related to hemorrhage and that caused the case subject to seek medical 
attention.  To establish the focal time, a detailed account of the patient’s symptoms from 
onset to diagnosis was obtained.  When necessary, acquaintances or witnesses were 
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consulted to determine the course of the illness.  As expected, there were patients who 
had symptoms compatible with a hemorrhagic stroke that predated the onset of symptoms 
that caused them to seek medical attention.  For those patients, the onset of early 
symptoms was defined s the secondary (alternate) focal time.  The focal time for control 
subjects was defined by the day of the week and time of day that marked the case 
subject’s focal time.  The index day was set within 7 days of the control interview. 
 
Delayed Diagnosis Study 
 
Selection of Case Subjects for the Study on Delayed Diagnosis 
 
HSP case subjects for whom diagnosis of SAH or ICH was delayed were selected 
as the case subjects for the study on delayed diagnosis.  These case subjects with delayed 
diagnosis will be referred to as “patient” for the study on delayed diagnosis.  Delayed 
diagnosis was defined when HSP case subjects did not receive an appropriate diagnostic 
evaluation within twenty-four hours of consulting a physician for symptoms consistent 
with SAH or ICH.  Consultation could have been in person or by telephone.  An 
appropriate diagnostic evaluation was recognized when a CT scan was obtained.  An 
additional requirement for SAH was that an LP must be performed if the CT scan was 
negative.  Among the 702 case-subjects in the HSP, patients for the delayed diagnosis 
study were identified with two strategies.  First, during the subject interview, all subjects 
were asked, “Did you see a physician in the 2-week period before the index date?”  
Second, case subjects were identified by a manual search of each subjects’ research 
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record, which included discharge summaries, admit notes, and histories of the stroke 
event recorded by research associates. 
 
Selection of Controls for the Study on Delayed Diagnosis 
 
HSP subjects who received a prompt, correct diagnosis were eligible as control 
subjects in the delayed diagnosis study.  Each patient was matched to a control subject 
according to research site because we believed that geographical location might be 
associated both with features we were studying and a delayed diagnosis.  To 
operationalize matching, control subjects were chosen as the next two patients enrolled in 
the HSP after the case subject.  To achieve greater statistical power, we selected two 
controls for each case subject. 
 
Baseline Data 
 
All data was obtained from the HSP database except when noted with an “*”.  
Data marked by “*” was obtained from the research forms, which contain a description of 
the neurologic event as given by the patient.  These narratives included an account of 
symptoms, precipitating activities, and actions taken by the patient during the symptoms 
of their stroke event.  The specific data collected were grouped into demographic and 
historical features, symptom features, and diagnostic features.  Features are shown in the 
following table: 
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Features Selected for Data Collection 
  
Demographic and 
Historical Features 
Symptom Features Diagnostic Features 
   
Age Headache Location of Presentation 
(Hospital vs. Office vs. 
Telephone) * 
Gender Photophobia  
History of Migraine 
Headaches 
Nausea/Vomiting  
Ethnicity Loss of Consciousness *  
Socio-economic Status Focal Neurological 
Symptoms 
 
Presence of Risk Factors 
(Hypertension, Cigarettes, 
and Cocaine) 
Facial Pain *  
Family History Neck Pain  
Insurance Status Upper Respiratory Tract 
Symptoms (URI, Allergies, 
Nasal Congestion) 
 
 Activity at Onset  
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Selection of Features 
 
We hypothesized that certain demographic and historical features, symptom 
features, and diagnostic features of patients may have an association with delayed 
diagnosis of hemorrhagic stroke.  Our hypothesis was made based on the fact that 
physicians make their diagnoses based on recognition of historical occurrences and 
physical exam.  Of the demographic features, we hypothesized that young age would be 
associated with delayed diagnosis because the typical patients with SAH or ICH are 
thought to be older persons with medical risk factors.  We also hypothesized that 
ethnicity could play a role in delayed diagnosis, with Hispanic ethnicity holding the most 
association with delayed diagnosis and Black ethnicity holding the least association with 
delayed diagnosis.  For gender, we hypothesized that females would be more likely to 
have a delayed diagnosis because of the protective effects of estrogens on the 
cardiovascular system. 
Of the historical features, we hypothesized that having a history of migraine 
diagnosis, no history of hypertension, no history of smoking, and no primary family 
history would be associated with increased risk for delayed diagnosis because a migraine 
diagnosis could skew the physician’s perception of a headache.  Patients without a high 
risk of cardiovascular disease (hypertension, smoking, and family history) would be more 
likely to have a delayed diagnosis because they are seen as “low-risk” patients.  We also 
hypothesized that having no college education and having no insurance would be 
associated with an increased risk for delayed diagnosis secondary to bias from financial 
burdens. 
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Of the symptom features, we hypothesized that no photophobia, no loss of 
consciousness, no focal neurological symptoms, the combination of which will be 
referred to as no alarm symptoms, will have increased association with delayed diagnosis 
of hemorrhagic stroke.  This is because mild symptoms will most likely lead a physician 
to not consider a diagnosis of hemorrhage.  Patients who present without facial or neck 
pain or without a headache would also be likely to have a delayed diagnosis because 
these symptoms are common to the presentation of hemorrhagic stroke.  We also 
hypothesized that nausea and vomiting symptoms would be associated with an increased 
risk of delayed diagnosis because the symptoms could distract the physician into 
diagnosing a gastrointestinal disorder.  The presence of upper respiratory tract infection 
symptoms, allergies, or nasal congestion, which will be combined into upper respiratory 
tract symptoms, within the last two weeks prior to the stroke event will be associated with 
an increased risk of delayed diagnosis because these symptoms can distract the physician 
into attributing these symptoms to an upper respiratory tract cause.  Finally, if the patient 
did not have an effortful activity preceding their stroke event, we hypothesize that this 
will be associated with an increased risk of delayed diagnosis. 
For diagnostic features, location of initial evaluation in a physician’s office or by 
telephone, which will be combined and referred to as office, will be associated with 
increased risk of delayed diagnosis because of the lack of diagnostic equipment, such as a 
CT scanner, in the office setting.  Patients who present to a physician’s office will be 
compared with patients who present to a hospital emergency room. 
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Analytic Strategy 
 
Odds ratios were calculated for the association between pre-specified suspected 
risk factors and risk for delayed diagnosis.  Chi-square was used to calculate p-values.  
Features were considered to be associated with delayed diagnosis of hemorrhagic stroke 
if the odds ratios were greater than or equal to 2.0 or less than or equal to 0.5.  To 
confirm their independent association with risk for hemorrhagic stroke, features with and 
odds ratio =2.0 or =0.5 were included in a multivariable logistic regression analysis.  
Features were considered confirmed if their adjusted odds ratios remained =2.0 or =0.5. 
 
RESULTS 
I. Study Participants 
 
Between December 1994 and July 1999, 702 case subjects were recruited for the 
Hemorrhagic Stroke Project from hospitals located in Connecticut, Southern 
Massachusetts, Southern Ohio, Northern Kentucky, Rhode Island, and Texas.  Among all 
case subjects, the diagnosis of intracranial hemorrhage was delayed for 54 patients 
(7.7%) and prompt for 648 patients (92.3%).  For each patient with a delayed diagnosis, 
we identified two control subjects.  Patients were matched (100%) to control subjects by 
geographic location. 
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II. Delayed Diagnosis Study Participants 
 
To identify features associated with increased risk for delayed diagnosis we 
compared patients with delayed and prompt diagnosis, as shown in Table E.  Features are 
described according to our hypotheses of how each feature may contribute to a delayed 
diagnosis.  The median age for patients was 40 years compared with 43 years for control 
subjects.  Of the patients, 34 of the 54 (63%) were ethnically Caucasian, 8 of the 54 
(15%) were Black, and 8 of the 54 (15%) were Hispanic.  Of the control subjects, 76 of 
108 (70%) were Caucasian, 21 of the 108 (20%) were Black, and, 8 of the 108 (7%) were 
Hispanic.  A similar number of patients (50%) and control subjects (53%) were female. 
 
III. Risk Factors for Delayed Diagnosis in The Overall Cohort 
 
Table E compares patients and control subjects with respect to demographic and 
historical features, symptom features, and diagnostic features.  Eight features were 
associated with risk for delayed diagnosis (criteria = odds ratio=2.0 or =0.5).  Compared 
to patients with a prompt diagnosis, patients with a delayed diagnosis tended to be of 
younger age (odds ratio=2.0, p=0.05), of Hispanic ethnicity (compared to non-Hispanic 
ethnicity) (odds ratio=2.2, p=0.14), non- hypertensive (odds ratio=2.0, p=0.04), and less 
educated (odds ratio=0.5, p=0.05).  Compared to patients with a prompt diagnosis, 
patients with a delayed diagnosis more often presented without alarm symptoms 
(photophobia, loss of consciousness, and focal neurological symptoms) (odds ratio=5.3, 
p=<0.01) and reported no effortful activity preceding their stroke event (odds ratio=3.0, 
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p=0.08).  However, compared to patients with a prompt diagnosis, patients with a delayed 
diagnosis were less likely to have no headache (odds ratio=0.2, p=0.02).  Finally, 
compared to patients with a prompt diagnosis, patients with a delayed diagnosis more 
often initially presented to a physician’s office rather than an emergency room (odds 
ratio=18.3, p=<0.01). 
Table F shows the results of the multivariable analysis, which includes the eight 
features with a bivariate odds ratio that were statistically significant according to the 
criteria of an odds ratio =2.0 or =0.5.  Among the eight variables in the multivariable 
analysis, there were four that remained independently associated with risk for delayed 
diagnosis (criteria odds ratio =2.0 or =0.5): 1) office evaluation (adjusted odds ratio 
23.1), 2) no alarm symptoms (adjusted odds ratio 4.6, with a 13% change), 3) no effortful 
activity (adjusted odds ratio 5.5), and 4) Hispanic ethnicity (adjusted odds ratio 2.4).  
Four variables were not longer independently associated with delayed diagnosis.  For no 
history of hypertension, the adjusted odds ratio was 1.5.  For age <40, the adjusted odds 
ratio was 1.2.  For no college education, the odds ratio was 0.9.  For no headache present, 
the odds ratio was 0.6. 
 
IV. Risk Factors for Delayed Diagnosis According to Type of Initial Contact 
 
Because location of initial presentation was associated with such a large adjusted 
odds ratio (23.1), we hypothesized that persons who present to an office may be 
sufficiently different to warrant a stratified analysis.  Accordingly, we examined the 
association between location of presentation and risk feature separately for patients with 
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prompt and delayed diagnoses.  Our criteria for declaring that a feature was different with 
regards to risk of delayed diagnosis by location of presentation was if the odds ratio was 
=2.0 in one location and the odds ratio was <1.2 in the other location or if the odds ratio 
was =0.5 in one location and the odds ratio was >0.8 in the other location.  Additionally, 
our criteria for declaring that a feature was a risk factor for delayed diagnosis in both 
locations of presentation was if the odds ratio was =2.0 in both locations.  Our criteria for 
declaring that a feature was a protective factor for delayed diagnosis in both locations of 
presentation was if the odds ratio was =0.5 in both locations.  Our criteria for declaring 
that a feature was associated with an increased risk for delayed diagnosis in one location 
and neutral in the other was if the odds ratio was =2.0 in one location and between 1.2-
2.0 in the other. Our criteria for declaring that a feature was considered to be protective 
for delayed diagnosis in one location and neutral in the other was if the odds ratio was 
=0.5 in one location and between 0.5 and 0.8 in the other.  The results of the stratified 
analysis are displayed in Table G. 
Nine features had a different effect on risk for delayed diagnosis in the office and 
hospital: young age, female gender, history of migraine diagnosis, not currently a smoker, 
no college education, no alarm symptoms, nausea, upper respiratory tract symptoms, and 
stroke type of ICH.  For three of these nine features (young age, history of migraine 
diagnosis, and no alarm symptoms) a delayed diagnosis was significantly increased when 
patients presented to the hospital, but were protective or neutral when patients presented 
to an office.  For young age, the odds for delayed diagnosis was 2.0 among patients who 
presented to the hospital compared with 0.4 among patients who presented to the office.  
For history of migraine diagnosis, the odds for delayed diagnosis was 2.1 among patients 
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who presented to the hospital compared with 0.4 among patients who presented to the 
office.  For no alarm symptoms, the odds for delayed diagnosis was 4.9 among patients 
who presented to the hospital compared with 1.1 among patients who presented to the 
office.  For four of the nine features (female gender, not currently a smoker, upper 
respiratory tract symptoms, and stroke type of ICH), a delayed diagnosis was protective 
or neutral when patients presented to the hospital, but were significantly increased when 
patients presented to an office.  For female gender, the odds for delayed diagnosis was 
0.9 among patients who presented to the hospital compared with 2.0 among patients who 
presented to the office.  For not currently a smoker, the odds for delayed diagnosis was 
1.1 among patients who presented to the hospital compared with 3.2 among patients who 
presented to the office.  For upper respiratory tract symptoms, the odds for delayed 
diagnosis was 0.9 among patients who presented to the hospital compared with 2.0 
among patients who presented to the office.  For stroke type of ICH, the odds for delayed 
diagnosis was 1.1 among patients who presented to the hospital compared with 4.3 
among patients who presented to the office.  
For the remaining two features (no college education and nausea), a delayed 
diagnosis was significantly decreased when patients presented to the office, but was 
neutral when patients presented to a hospital.  For no college education, the odds for 
delayed diagnosis was 0.1 among patients who presented to the office compared with 1.0 
among patients who presented to the hospital.  For nausea, the odds for delayed diagnosis 
was 0.3 among patients who presented to the office, compared to1.5 among patients who 
presented to the hospital. 
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Only one feature was associated with an increased risk of delayed diagnosis in 
both the hospital and the office.  For no effortful activity, the odds for delayed diagnosis 
was 4.2 among patients who presented to the hospital compared with 2.6 among patients 
who presented to the office. 
One feature was associated with an increased risk for delayed diagnosis in one 
location and a neutral association in the other: no hypertension history.  For no 
hypertension history, the odds for delayed diagnosis was 1.6 among patients who 
presented to the hospital compared with 3.0 among patients who presented to the office. 
 
V. Risk Factors for Delayed Diagnosis According to Stroke Type  
 
Because type of stroke of ICH was associated with such a large odds ratio (4.3) in 
the office location and because the pathophysiology of the diseases are substantially 
different from each other, we hypothesized that persons who present with a SAH may be 
different from those who present with an ICH.  Accordingly, we examined the 
association between type of stroke type risk feature separately for patients with prompt 
and delayed diagnoses. Our criteria for declaring that a feature was different with regards 
to risk of delayed diagnosis by location of presentation was if the odds ratio was =2.0 in 
one location and the odds ratio was <1.2 in the other location.  Additionally, our criteria 
for declaring that a feature was a risk factor for delayed diagnosis in both locations of 
presentation was if the odds ratio was =2.0 in both locations.  Our criteria for declaring 
that a feature was a protective factor for delayed diagnosis in both locations of 
presentation was if the odds ratio was =0.5 in both locations.  Our criteria for declaring 
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that a feature was associated with an increased risk for delayed diagnosis in one location 
and neutral in the other was if the odds ratio was =2.0 in one location and between 0.5-
2.0 in the other. Our criteria for declaring that a feature was considered to be protective 
for delayed diagnosis in one location and neutral in the other was if the odds ratio was 
=0.5 in one location and 0.5 to 0.8 in the other.  The results of the stratified analysis are 
displayed in Tables H and I. 
Ten features had a different effect on risk for delayed diagnosis of SAH compared 
to ICH: Caucasian ethnicity, Black ethnicity, female gender, history of migraine 
diagnosis, no hypertension history, no neck pain, nausea, vomit, upper respiratory tract 
symptoms, and no effortful activity.  For two of these ten features (no neck pain, and no 
effortful activity) a delayed diagnosis was significantly increased for patients with SAH, 
but was protective or neutral for patients with ICH.  Black ethnicity was a significantly 
protective feature for delayed diagnosis of ICH, but was a risk for delayed diagnosis for 
patients with SAH.  For no neck pain, the odds for delayed diagnosis was 2.9 among 
patients with SAH compared with 0.4 among patients with ICH.  For no effortful activity, 
the odds for delayed diagnosis was 6.9 among patients with SAH compared with 0.9 
among patients with ICH.  For Black ethnicity, the odds for delayed diagnosis was 1.3 
among patients with SAH compared with 0.4 among patients with ICH.  For five of the 
ten features (Caucasian ethnicity, female gender, history of migraine diagnosis, no 
hypertension history, and nausea) a delayed diagnosis was significantly increased for 
patients with ICH, but was protective or neutral for patients with SAH.  The remaining 
two features, vomiting, and upper respiratory tract symptoms, were significantly 
protective for delayed diagnosis of SAH, but were associated with risk for delayed 
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diagnosis of ICH.  For Caucasian ethnicity, the odds for delayed diagnosis was 2.0 
among patients with ICH compared with 0.6 among patients with SAH.  For female 
gender, the odds for delayed diagnosis was 3.8 among patients with ICH compared with 
0.3 among patients with SAH.  For history of migraine diagnosis, the odds for delayed 
diagnosis was 2.4 among patients with ICH compared with 0.9 among patients with SAH.  
For no hypertension history, the odds for delayed diagnosis was 5.9 among patients with 
ICH compared with 1.0 among patients with SAH.  For nausea, the odds for delayed 
diagnosis was 2.7 among patients with ICH compared with 0.6 among patients with SAH.  
For vomiting, the odds for delayed diagnosis was 1.5 among patients with ICH compared 
with 0.5 among patients with SAH.  For upper respiratory tract symptoms, the odds for 
delayed diagnosis was 1.5 among patients with ICH compared with 0.5 among patients 
with SAH. 
Two features were associated with an increased risk of delayed diagnosis in both 
SAH and ICH: no alarm symptoms and office evaluation.  For no alarm symptoms, the 
odds for delayed diagnosis was 3.0 among patients who had a SAH compared with 18.5 
among patients who had an ICH.  For office evaluation, the odds for delayed diagnosis 
was 12.4 among patients who had a SAH compared with 47.3 among patients who had an 
ICH. 
Three features were associated with an increased risk for delayed diagnosis in one 
location and a neutral association in the other: Hispanic ethnicity, no college education, 
and no headache present.  For Hispanic ethnicity, the odds for delayed diagnosis was 1.9 
among patients who had a SAH compared with 2.5 among patients who had an ICH.   For 
no college education, the odds for delayed diagnosis was 0.6 among patients who had a 
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SAH compared with 0.4 among patients who had an ICH.  For no headache present, the 
odds for delayed diagnosis was 0.7 among patients who had a SAH compared with 0.1 
among patients who had an ICH.
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DISCUSSION 
 
Among 702 young men and women with hemorrhagic stroke, the diagnosis was 
delayed diagnosis for 54 (7.7%).  Features associated with increased risk of delayed 
diagnosis were Hispanic ethnicity (adjusted odds ratio=2.4), no effortful activity 
preceding stroke event (adjusted odds ratio=5.5), no alarm symptoms (adjusted odds 
ratio=4.6), office evaluation (adjusted odds ratio=23.1). 
This is the first study to demonstrate the importance of location of presentation in 
understanding the phenomenon of delayed diagnosis.  Because of the magnitude of the 
adjusted odds ratio for the office evaluation features, we hypothesized that persons who 
present to an office may be sufficiently different from those who present to a hospital 
emergency room to warrant a stratified analysis.  Our results did, in fact, show that 
features associated with delayed diagnosis were different based on location of initial 
presentation.  There were nine features that had a different effect on risk for delayed 
diagnosis in the office and hospital: young age, female gender, history of migraine 
diagnosis, not currently a smoker, no college education, no alarm symptoms, nausea, 
upper respiratory tract symptoms, and stroke type of ICH. 
Additionally, this is the first study to examine the association of risk features for 
delayed diagnosis in both SAH and ICH.  Comparison of risk features for delayed 
diagnosis of SAH and ICH showed that features associated with delayed diagnosis of 
SAH were different from those associated with delayed diagnosis of ICH.  Ten features 
had a different effect on risk for delayed diagnosis of SAH compared to ICH: Caucasian 
ethnicity, Black ethnicity, female gender, history of migraine diagnosis, no hypertension 
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history, no neck pain, nausea, vomit, upper respiratory tract symptoms, and no effortful 
activity. 
The results of the overall cohort analysis conclude that patients who present to 
their physician’s office with milder clinical symptoms (no alarm symptoms) are more 
likely to have a delay in diagnosis of hemorrhagic stroke.  No alarm symptoms was 
associated with increased risk of delayed diagnosis because when patients present with 
mild symptoms, physicians usually think of less catastrophic causes.  The usual 
presentation for ruptured aneurysm or intracranial bleed occurs when patients are 
performing activities that require some effort.  Therefore, patients who present without 
having done any effortful activity preceding the onset of the hemorrhagic stroke are more 
likely to have a delay in diagnosis.  Hispanic ethnicity may be associated with increased 
risk of delayed diagnosis because of a language barrier between patient and physician.  
Without an adequate interpreter, physicians may not obtain the full history of symptoms, 
and therefore, may not consider the diagnosis of hemorrhagic stroke. 
In evaluating the features associated with delayed and prompt diagnosis, an 
important finding from our study was that most cases of delayed diagnosis of intracranial 
hemorrhage occurred in patients who presented to a physician’s office.  This has not been 
reported in previous studies.  Prior studies never made a comparison between patients 
based on the location of initial presentation, and therefore, they have never demonstrated 
that location of initial examination is important.  The one common conclusion of prior 
studies has been that physician diagnosis is the reason for delayed diagnosis.  This 
conclusion merely recognizes that delayed diagnosis is common, however, it does not 
help to identify the features that are associated with delayed diagnosis.  Our study, by 
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examining the features that become risk factors for delayed diagnosis, helps physicians to 
know what to look for so that SAH and ICH can be promptly diagnosed.  We speculate 
that this increased risk of delayed diagnosis in the office location may be due to the fact 
that patients who present to an office or by telephone have milder symptoms.  Our data 
supports this, as is seen in Table J, where there was a higher percentage of patients who 
presented to the office without alarm symptoms or facial pain.  Also, more patients who 
present to the office or by telephone have symptoms that were not related to any effortful 
activity. 
Our results also show that risk factors associated with delayed diagnosis are 
different among patients who initially present to a physician in a hospital versus in an 
office.  No effortful activity is a feature that was associated with delayed diagnosis in 
both locations of presentation.  Physicians look at the symptoms and the presenting 
history to determine a differential diagnosis of disease.  Their differential diagnosis is 
based on previous cases of the disease they have encountered.  Since most patients with 
SAH or ICH present with symptoms after exerting themselves, it is less likely for 
physicians to think of ruptured aneurysms or vessels in patients who had no history of 
exerting themselves when their symptoms began. 
Features associated with delayed diagnosis in patients who present to the hospital, 
but not those who present to an office setting are: young age, history of migraine 
diagnosis, and no alarm symptoms.  There is a tendency for delayed diagnosis of 
hemorrhagic stroke in younger patients who present to the hospital because physicians do 
not commonly think of hemorrhagic stroke in a younger person.  Additionally, physicians 
in an office may be more concerned about younger patients who present to them because 
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younger patients are usually healthy and any symptoms that are persistent are not 
ordinary.  Therefore, physicians in an office may have a lower threshold to send younger 
patients for further evaluation.  A history of migraine diagnosis may result in delayed 
diagnosis in the hospital, especially if the presenting symptoms are mild, because 
migraine or tension headaches are the more common diagnoses seen in the emergency 
room compared to hemorrhagic stroke.  In the office, if a patient has a history of migraine 
diagnosis, multiple headaches will lead the physician to send the patient for a work-up.  
When the patient does not have any alarm symptoms, the mild symptoms in patients who 
present to the hospital leads the physicians toward a milder differential diagnosis.  
Physicians in the office setting may send the patient for a work-up, even though the 
presenting symptoms may be mild, because they reason that if the symptoms were bad 
enough for the patient to make an appointment, there must be some validity to the 
symptoms. 
There are three features that are associated with a delayed diagnosis in the office 
or telephone setting, but are neutral in the hospital: female gender, no history of smoking, 
and upper respiratory tract infection symptoms.  The presence of these features made no 
difference when the patient presented to a hospital.  However, when patients who 
presented to an office or by telephone with these features, they were more likely to have a 
delayed diagnosis.  This may be due to the fact that physicians in the office or by 
telephone tend to downplay the complaints of women, especially if the woman has 
complained before of symptoms such as headache.  Physicians in an office also see 
multiple cases of allergies and nasal congestion, that a person who presents with upper 
respiratory tract infection symptoms is most likely to have a cold or allergies. 
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There are two features that are protective for delayed diagnosis in patients who 
initially present to an office or by telephone: nausea and no college education.  Nausea 
may lead to a more prompt diagnosis because nausea is a symptom that is commonly 
associated with a neurological etiology.  Therefore, patients will get worked up quicker.  
Patients with a college education who presented to an office or via telephone had a 
significant risk of delayed diagnosis of hemorrhagic stroke.  Perhaps this is due to 
physicians being reluctant to send college educated patients to the emergency room for 
mild symptoms.  Alternatively, educated patients may downplay their symptoms because 
they reason that their symptoms are probably something insignificant.  Also, physicians 
may feel more comfortable to follow educated patients instead of immediately treat 
because they believe that educated patients will be able to recognize worsening 
symptoms and seek additional medical care if their symptoms get worse.  On that line of 
reasoning, less educated patients who present to their physician’s office or by telephone 
would be more readily sent to the emergency room for fear that the less educated patient 
will not return for medical care if they are sent away. 
A feature associated with risk of delayed diagnosis in the office only is no history 
of hypertension.  This risk factor is also slightly increased in patients who present to the 
hospital.  Once again, physicians are trained to recognize constellation of symptoms and 
histories.  Since studies have proven that hypertension leads to vessel disease and 
coronary artery disease, it is less likely for physicians to think that patients without 
hypertension could have pre-disposing features that would lead to hemorrhagic stroke. 
A feature associated with risk of delayed diagnosis in the hospital only is 
Hispanic ethnicity.  This is most likely due to a language barrier in the hospital.  Hispanic 
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patients who have a primary care physician usually go to a clinic with a physician who 
speaks Spanish, leading to a direct interpretation of the history by the medical provider. 
Our study of risk factors demonstrates the importance of distinguishing patients 
who present to a hospital versus patients who present to an office or by telephone.  Two 
conclusions can be drawn from this portion of our study (Table G).  It appears that there 
are different risk factors pertaining to delayed diagnosis in the different settings of 
medical care and that it may be inappropriate to combine patients who present to a 
hospital for their care and patients who present to an office or call a physician via 
telephone.  One limitation of this portion of the study is that there were so few patients 
with prompt diagnosis who presented to an office or via telephone.  With such a small n, 
it was hard to draw more conclusions based on office or telephone presentation.  A clear 
conclusion is that absence of alarm symptoms is an important factor of delayed diagnosis 
in the hospital emergency room.  Also, patients with a college education who present to 
an office or via telephone need to have more prompt action taken for their mild 
symptoms that are consistent with SAH or ICH. 
Analyzing the risk factors by stroke type reveals that features of presentation of 
SAH and ICH are distinct from the other.  There are two features associated with a risk 
for delayed diagnosis of both SAH and ICH: no alarm symptoms and office presentation.  
Presentation with mild symptoms consistent with SAH or ICH will lead most physicians 
to think of other diagnoses than hemorrhagic stroke.  Presentation to an office with 
symptoms consistent with SAH or ICH is associated with an increased risk of delayed 
diagnosis.  As discussed previously, the increased risk of delayed diagnosis in the office 
could be because patients who go to a physician’s office present with milder symptoms 
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than patients who go immediately to an emergency room for symptoms that frighten 
them. 
It is known that the pathophysiology of SAH and ICH are very different.  The 
typical presentation of each disease is distinct from the other.  This became apparent in 
the evaluation of risk features for delayed diagnosis based on location of presentation, 
where ICH was associated with such an odds ratio of 4.3.  We hypothesized that features 
associated with delayed diagnosis in persons who present with a SAH may be different 
from those in persons who present with an ICH.  There were ten features examined that 
had a different effect on risk for delayed diagnosis of SAH compared to ICH: Caucasian 
ethnicity, Black ethnicity, female gender, history of migraine diagnosis, no hypertension 
history, no neck pain, nausea, vomit, upper respiratory tract symptoms, and no effortful 
activity. 
For three of these ten features (Black ethnicity, no neck pain, and no effortful 
activity) a delayed diagnosis was increased for patients with SAH, but was protective or 
neutral for patients with ICH.   The usual presentation of SAH is acute onset of headache 
with decreased consciousness and nuchal rigidity due to a ruptured aneurysm, commonly 
associated with increased intracranial pressure due to some strenuous activity.  Therefore, 
if a patient does not have neck pain, physicians are led to think that a headache is a 
migraine or tension headache.  Also, if there is no effortful activity at the onset of 
symptoms, physicians may think that the symptoms are from something else besides 
SAH.  Black ethnicity is a protective feature for delayed diagnosis of ICH.  This may be 
attributed to the fact that physicians are aware that people of Black ethnicity have a 
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higher risk of hypertension and coronary artery disease.  Therefore, when people of Black 
ethnicity present to a physician for any symptoms, they are more likely to be worked up.  
For five of the ten features (Caucasian ethnicity, female gender, history of 
migraine diagnosis, no hypertension history, and nausea) a delayed diagnosis was 
significantly increased for patients with ICH, but was protective or neutral fo r patients 
with SAH.  It is unclear why Caucasian ethnicity may be associated with delayed 
diagnosis of ICH.  Female gender may lead to an increased risk of delayed diagnosis 
because women may have migraine headaches associated with their menstrual cycle, so 
headache symptoms may be attributed to other illnesses.  History of migraine headaches 
may be associated with increased delay in diagnosis of ICH because headaches may be 
attributed to the migraine diagnosis than hemorrhage.  Since the usual patients with ICH 
are hypertensive, if a patient does not have a history of hypertension, the diagnosis of 
ICH will fall lower on the differential. Nausea is associated with a delayed diagnosis of 
ICH because nausea can be attributed to GI distress, and therefore be overlooked as a 
symptom of ICH. 
The remaining two features, vomiting and upper respiratory tract symptoms, were 
significantly protective for delayed diagnosis of SAH, but were associated with risk for 
delayed diagnosis of ICH.  Vomiting is one of the signs seen with increased intracranial 
pressure, which leads physicians to get a CT scan in order to rule out increased 
intracranial pressure.  Blood from SAH can be seen easily on CT scan.  CT scan may not 
pick up some ICH.  Upper respiratory tract symptoms may also lead to diagnostic 
evaluation by CT scan or MRI, which allows blood to be picked up.  Again, diagnostic 
studies may not pick up small ICH. 
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Three features were associated with an increased or decreased risk for delayed 
diagnosis of ICH and a neutral effect on SAH: Hispanic ethnicity, no college education, 
and no headache present.  Hispanic ethnicity tends to be a risk for delayed diagnosis of 
ICH, but has a neutral (albeit barely neutral) effect on SAH.  This may be due to severity 
of symptoms from ICH versus SAH.  If the patient presents with small hemorrhages in 
the basal ganglia due to ICH, it may be difficult for the physician to locate a focal 
neurological deficit, whereas if an aneurysm ruptures, as in SAH, focal deficits are 
usually more obvious.  Therefore, less interpretation is required when evaluating a patient 
with ruptured SAH, possibly accounting for the difference in Hispanic ethnicity.  
Features that are protective for delayed diagnosis of ICH are no college education and no 
headache.  Reasons for delay if a patient is more educated have been discussed 
previously.  However, no headache as a protective feature may be because of location of 
the ICH.  Some patients with ICH present without any headache, but with other 
neurological deficits.  These patients are more likely to be worked up, thereby leading the 
results to consider no headache as a protective feature. 
The results of our study are strikingly different from previous studies on delayed 
diagnosis of SAH.  Only 54 of 702 (7.7%) patients had a delayed diagnosis of 
hemorrhagic stroke.  This estimate compares to 15% to 64% in other published research. 
(20)(18) The reason that our estimate may be lower than other studies include: 1) we only 
enrolled patients who survived their hemorrhagic stroke 2) younger patients are more 
likely to seek medical care, and 3) the rigorous case definition that was strictly adhered to 
minimized misclassification.  In terms of patient selection, our cohort excluded people 
who had died from their neurological event.  However, based on our data thus far, most 
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of the patients who have a delayed diagnosis are more likely to have worse outcome.  
Therefore, excluding those who had died would only support our results that delayed 
diagnosis leads to increase morbidity and mortality.  In terms of methodology, bias was 
minimized during data collection by including participants not only presenting at the 
hospital, but also presenting initially to a physician in an office or by telephone.  
Additionally, trained individuals who used active surveillance to identify patients 
collected data from hospitals in four geographical regions.  There was no doubt of 
diagnosis in our study because of the strict definition of delayed diagnosis that was 
adhered to throughout the study requiring that a diagnosis of SAH or ICH be proven with 
a CT scan or by LP.   To minimize recall bias, patients were asked the same questions 
regarding their event from an interview booklet.  Additionally, medical records were 
read, and patients and family members were interviewed in detail to classify the patient 
according to pre-specified criteria for delay.  We are confident that this study is a true 
estimate of risk factors for delayed diagnosis of SAH and ICH. 
 
Conclusion 
 
In summary, our study has shown that features associated with increased risk of 
delayed diagnosis were Hispanic ethnicity, no effortful activity preceding stroke event, 
no alarm symptoms, and office evaluation.  When we further stratified the analysis based 
on location of presentation, our study showed that the features associated with delayed 
diagnosis of hemorrhagic stroke were different in patients who presented to an office 
compared with an emergency room.  Finally, stratification by stroke type determined that 
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SAH and ICH must be studied separately, as risk factors for delayed diagnosis of SAH 
differed from those of ICH. 
The results of our study will be helpful to recognize those patients with 
hemorrhagic stroke who do not present with the classic symptoms for SAH or ICH.  By 
recognizing the features that are associated with delayed diagnosis of hemorrhagic stroke, 
prompt diagnosis can be made and early patient referral for treatment can be 
implemented.  Early patient referral will help to decrease risk of vasospasm and re-bleed 
in the 3-4 days following the initial event, and thus decrease the morbidity and mortality 
rates of patients with intracranial hemorrhage. (16, 20, 22)   
Stratifying the risk features showed that there are different risk factors for delayed 
diagnosis based on location that patients present to with their initial symptoms of 
hemorrhagic stroke.  An important conclusion is that patients were more likely to have a 
delayed diagnosis if they went to see a physician in an office.  Results for associated risk 
factors based on location of presentation were consistent with the initial analysis of 
features leading to increased risk of delayed diagnosis.  Young patients who presented to 
the office without any alarm symptoms were more likely to have a delayed diagnosis.  
The results of this case-control study have also shed some light on the risk factors that 
can lead to delayed diagnosis of ICH.  Risk factors for delayed diagnosis of SAH and 
ICH are very different, which supports the fact that clinical features of SAH and ICH 
should be studied as separate diseases rather than be combined as hemorrhagic stroke.  
Our study has shown that there are many features of patients who present with ICH 
which need to be considered in patients who come with symptoms suggestive of ICH.  In 
particular, physicians who see young women with no history of hypertension in their 
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office or who speak with them via telephone need to consider the diagnosis of ICH more 
strongly.  In addition, further history and evaluation need to be obtained in patients who 
present with headache in order to be sure that a diagnosis of ICH is not missed. 
There have been many studies investigating delayed diagnosis in subarachnoid 
hemorrhage, but only one study that included delayed diagnosis in intracerebral 
hemorrhage. (22) These studies have been able to determine the outcome of the patients 
after the delay, but none have been able to determine factors that can lead to delayed 
diagnosis.  In addition, the studies performed were cross-sectional studies, which could 
not statistically conclude that certain risk factors were present for the delay in diagnosis. 
The results of our case-control study will aid physicians to be able to recognize 
presentations of SAH and ICH in order to promptly diagnose the hemorrhagic stroke and 
refer the patient for treatment as quickly as possible to reduce morbidity and mortality.  
The need to study ICH and SAH as separate entities is not a new idea, however, never 
before was the data regarding risk factors of presenting symptoms statistically analyzed.  
Our results show clearly that SAH and ICH must be looked at separately when studying 
risk factors that may lead to delayed diagnosis of each stroke type.  Our results also show 
that there is a difference in the risk factors associated with delayed diagnosis in the office 
setting compared with the hospital.  To further understand the phenomenon of delayed 
diagnosis and identify strategies to prevent it, it will be important to account for the 
important delay occurring in the office and to recognize that the risk factors for delayed 
diagnosis may be different according to where a patient initially presents. 
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Implications  
 
 Implications of our study show that efforts are needed to reduce delay in 
diagnosis among primary care physicians and hospital physicians who see low-risk 
patients who may present with mild initial symptoms.  Features associated with delayed 
diagnosis of SAH were vastly different from those associated with delayed diagnosis of 
ICH, proving that it is not sufficient to study hemorrhagic stroke as one entity.  Each 
specific stroke type needs to be studied on its own to determine more specific features 
associated with delayed diagnosis of each individual stroke type. 
Additionally, it appears that features associated with delayed diagnosis are 
different based on location of initial presentation of symptoms.  We recognize that 
evaluation of SAH and ICH based on location of initial medical contact was limited in 
this study because of small numbers.  However, the results that were obtained show that 
it would be worthwhile for future studies examining delayed diagnosis to separately 
evaluate the risk factors of those patients who initially present to a physician’s office 
from the patients who initially are seen in the emergency room. 
Additional studies are necessary to further understand delayed diagnosis of 
hemorrhagic stroke and to evaluate risk factors for delayed diagnosis in the hospital 
separate from the risk factors for delayed diagnosis in the physician’ s office.  By 
recognizing that most delayed diagnoses occur in an office, future studies will be able to 
determine the specific symptoms that physicians need to be aware of in each location of 
evaluation in order to reduce the incidence of delayed diagnosis of hemorrhagic stroke. 
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Figure 1.  Diagram of Cohort Assembly
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Table A: 
 
Presenting Symptoms of Subarachnoid Hemorrhage in 41 Patients with 
Delayed Diagnosis 
(Adams, et al., JAMA  244:794-796, 1980) 
 
Symptom No. of Patients (%) 
  
Headache 35 (85) 
Nausea 18 (44) 
Vomiting 14 (34) 
Brief Loss of Consciousness 13 (32) 
Neck Stiffness or Pain 6 (15) 
Hemiparesis 6 (15) 
Vertigo 6 (15) 
Faintness 5 (12) 
Confusion 3 (7) 
Convulsions 3 (7) 
Coma 3 (7) 
Hearing Loss 3 (7) 
Visual Loss 2 (5) 
Diploplia 2 (5) 
Malaise and Diffuse Aches 2 (5) 
Photophobia 1 (2) 
Back Pain 1 (2) 
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Table A (continued): 
 
Presenting Symptoms of Subarachnoid Hemorrhage in 41 Patients with 
Delayed Diagnosis 
(Adams, et al., JAMA  244:794-796, 1980) 
 
 
Leg Pain 1 (2) 
Ataxia 1 (2) 
Speech Disturbance 1 (2) 
Chest Pain 1 (2) 
Paraparesis 1 (2) 
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Table B: The Hunt and Hess Scale for Grading of Subarachnoid Hemorrhage 
Grade Motor Deficit 
  
0 Intact aneurysm. 
1 Asymptomatic. 
Mild headache and slight nuchal rigidity. 
1a No acute meningeal/brain reaction but with fixed neurological deficit. 
2 Cranial nerve palsy. 
Moderate to severe headache. 
Nuchal rigidity. 
3 Mild focal deficit. 
Lethargy or confusion. 
4 Stupor. 
Moderate to severe hemiparesis. 
Early decerebrate rigidity. 
5 Deep coma. 
Decerebrate rigidity. 
Moribund appearance. 
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Table C: The Glasgow Coma Scale* 
Glasgow Coma Scale 
 
Eye Opening (E) Verbal Response (V) Motor Response (M) 
 
4=Spontaneous 
3=To voice 
2=To pain 
1=No Eye Opening 
 
5=Normal conversation 
4=Disoriented conversation 
3=Words, but not coherent 
2=Incomprehensible sounds 
1=No Sounds 
 
6= Obeys commands fully 
5=Localizes to noxious stimuli 
4=Withdraws from noxious stimuli 
3= Abnormal flexion, i.e.       
decorticate posturing 
2= Extensor response, i.e. 
decerebrate posturing 
1= No response 
 
* Glasgow Coma Score is calculated as E+V+M 
 
 
Table D: Summary of Previous Studies on Delayed Diagnosis of Intracranial Hemorrhage 
 
Study (Year) Study Type Method of Patient 
Selection 
Source of Data Stroke Type 
Studied 
Number 
of 
Patients 
Delayed 
Diagnosis 
n (%) 
       
Adams et al. (1980) Cross-Sectional Discharge Diagnosis Medical Records SAH 182 41 (23) 
Jain et al. (1983) Cross-Sectional Discharge Diagnosis Medical Records SAH 90 31 (34) 
Kassell et al. (1985) Cross-Sectional Discharge Diagnosis Medical Records, 
patients, family 
members, physicians 
SAH 150 56 (37)* 
96 (64) 
Schievink et al. (1988) Cross-Sectional Discharge Diagnosis Medical Records SAH 334 52 (16)* 
164 (49) 
Fontanarosa (1989) Cross-Sectional Discharge Diagnosis Medical Records SAH 109 16 (15) 
 
* This percentage reflects delayed diagnosis due only to physician diagnostic error. 
 
 
 
 
 
Table D: Summary of Previous Studies on Delayed Diagnosis of Intracranial Hemorrhage 
 
 
Study (Year) Study Type Method of Patient 
Selection 
Source of Data Stroke Type 
Studied 
Number 
of 
Patients 
Delayed 
Diagnosis 
n (%) 
       
Ferro et al. (1991) Cross-Sectional Triage Surveillance Data Collected at Time 
of Admission; followed 
until referral to 
neurosurgical unit 
SAH 112 56 (50) 
Chan et al. (1991) Cross-Sectional Discharge Diagnosis Medical Records SAH 94 15 (16) 
Sved et al. (1995) Cross-Sectional Discharge Diagnosis Medical Records SAH 511  
Mayer et al. (1996) Cross-Sectional Discharge Diagnosis Medical Records SAH and ICH 217 54 (25) 
Neil-Dwyer et al. 
(1997) 
Cross-Sectional Discharge Diagnosis History and Data 
Collected at Time of 
Admission 
SAH 136 69 (51) 
 
* This percentage reflects delayed diagnosis due only to physician diagnostic error. 
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Table E: Baseline Features among patients with delayed and prompt diagnosis of 
hemorrhagic stroke* 
 
Demographic and Historical 
Features 
Delayed 
Diagnosis 
Prompt 
Diagnosis 
 
Odds Ratio 
 
P-value  
 N=54 
n (%) 
N=108 
n (%) 
  
     
Age, years (median) 40 43   
Age < 40 24 (44) 31 (29) 2.0 0.05 
Race/Ethnicity     
     Caucasian 43 (80) 85 (79) 1.1 0.89 
     Black 8 (15) 21 (19) 0.7 047 
     Hispanic 8 (15) 8 (7) 2.2 0.14 
Gender: Female 27 (50) 57 (53) 0.9 0.74 
History of Migraine Headaches 10 (19)† 15 (14)† 1.5 0.40 
No History of Hypertension 38 (70) 58 (54) 2.0 0.04 
Not Currently a Smoker 25 (46) 54 (50) 0.9 066 
No Family History 51 (94) 101 (94) 1.5 0.62 
No College Education 27 (50) 71 (66) 0.5 0.05 
No Insurance  9 (17)† 15 (14)† 1.3 0.62 
 
* features are described in table according to hypothesis of how each feature would 
contribute to delayed diagnosis 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table E: Baseline Features among patients with delayed and prompt diagnosis of 
hemorrhagic stroke* 
 
 
Symptom Features 
Delayed 
Diagnosis 
Prompt 
Diagnosis 
 
Odds Ratio 
 
P-value  
 N=54 
n (%) 
N=108 
n (%) 
  
     
No Alarm Symptoms 34 (63) 26 (24)† 5.3 <0.01 
     No Photophobia 45 (83) 79 (74)† 1.8 0.18 
     No Loss of Consciousness 50 (93) 85 (81)† 2.9 0.05 
     No Focal Neurological Sx 45 (83) 63 (58) 3.6 <0.01 
No Facial Pain 53 (98) 105 (97) 1.5 0.72 
No Neck Pain 35 (65) 57 (53) 1.6 0.14 
No Headache Present 2 (4)† 18 (17)† 0.2 0.02 
Nausea 27 (52)† 52 (50)‡ 0.9 0.87 
Vomiting 25 (48)† 57 (56)‡ 1.4 0.36 
Upper Respiratory Tract Sx 19 (39)‡ 47 (46)‡ 0.7 0.40 
     URI Symptoms 8 (16)‡ 19 (18)‡ 0.9 0.77 
     Allergies 9 (18)‡ 25 (24)‡ 0.7 0.43 
     Nasal Congestion 15 (29) 30 (29)‡ 1.0 1.00 
No Effortful Activity 50 (94)† 90 (85)† 3.0 0.08 
 
* features are described in table according to hypothesis of how each feature would 
contribute to delayed diagnosis 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table E: Baseline Features among patients with delayed and prompt diagnosis of 
hemorrhagic stroke* 
 
 
Diagnostic Features 
Delayed 
Diagnosis 
Prompt 
Diagnosis 
 
Odds Ratio 
 
P-value  
 N=54 
n (%) 
N=108 
n (%) 
  
     
Location of Evaluation: 
Office or Telephone 
28 (52) 6 (6) 18.3 <0.01 
Stroke Type: ICH 24 (44) 41 (38) 1.3 0.43 
 
* features are described in table according to hypothesis of how each feature would 
contribute to delayed diagnosis 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table F: Results of a Multivariable Analysis for clinical features associated with 
increased risk for delayed diagnosis 
 
 
Feature* Adjusted OR P-value  
   
Office or Telephone Evaluation 23.1 <0.0001 
No Alarm Symptoms 4.6 0.0013 
No Effortful Activity 5.5 0.08 
Hispanic Ethnicity 2.4 0.19 
No History of Hypertension 1.5 0.41 
Age < 40 1.2 0.68 
No College Education 0.9 0.92 
No Headache Present 0.6 0.51 
 
* Features were included in the model if the odds ratio in a bivariate analysis was > 2.0 or 
<0.5 (see Table E) 
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Table G: Features Associated with Delayed Diagnosis According to Type of Initial Contact 
 
 
 
 Presented to Hospital Presented to Office/by Telephone  
Demographic and 
Historical Features 
Delayed Prompt Odds 
Ratio 
P-
value  
Delayed Prompt Odds 
Ratio 
P-
value  
 N = 26 
n (%) 
N = 102 
n (%) 
  N = 28 
n (%) 
N = 6 
n (%) 
  
         
Age < 40 Years 11 (42) 27 (26) 2.0 0.11 13 (46) 4 (67) 0.4 0.37 
Race         
     Caucasian 20 (77) 79 (77) 1.0 0.95 23 (82) 6 (100) – 0.26 
     Black 6 (23) 21 (21) 1.2 0.78 2 (7) 0 (0) – 0.50 
     Hispanic 6 (23) 8 (8) 3.5 0.03 2 (7) 0 (0) – 0.50 
Female 13 (50) 55 (54) 0.9 0.72 14 (50) 2 (33) 2.0 0.46 
History of Migraine Dx 6 (24)† 13 (13)† 2.1 0.16 4 (15)† 2 (33) 0.4 0.29 
No Hypertension History 17 (65) 55 (54) 1.6 0.29 21 (75) 3 (50) 3.0 0.22 
Not Currently a Smoker 14 (54) 53 (52) 1.1 0.86 11 (39) 1 (17) 3.2 0.29 
No Primary Family History 25 (100)† 95 (94)† – 0.21 26 (93) 6 (100) – 0.50 
No College Education 17 (65) 66 (65) 1.0 0.95 10(36) 5 (83) 0.1 0.03 
Not Insured 5 (20)† 15 (15)† 1.4 0.53 4 (14) 0 (0) – 0.32 
 
* indicates that these symptoms were present the 2 weeks before initial presentation to physician 
for symptoms consistent with hemorrhagic stroke 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table G: Features Associated with Delayed Diagnosis According to Type of Initial Contact 
 
 Presented to Hospital Presented to Office/by Telephone  
Symptom Features Delayed Prompt Odds 
Ratio 
P-
value  
Delayed Prompt Odds 
Ratio 
P-
value  
 N = 26 
n (%) 
N = 102 
n (%) 
  N = 28 
n (%) 
N = 6 
n (%) 
  
         
No Alarm Symptoms 15 (58) 22 (22)† 4.9 0.0003 19 (68) 4 (67) 1.1 0.95 
     No Photophobia  21 (81) 75 (74)† 1.5 0.49 24 (86) 4 (67) 3.0 0.27 
     No Loss of 
     Consciousness 
23 (88) 79 (80)† 1.9 0.31 27 (96) 6 (100) – 0.64 
     No Focal Weakness 22 (85) 57 (56) 4.3 0.007 23 (82) 6 (100) – 0.26 
No Facial Pain 25 (96) 99 (97) 0.8 0.81 28 (100) 6 (100) –   
No Neck Pain 17 (65) 57 (56) 1.5 0.38 18 (64) 0 (0) – 0.004 
No Headache Present 1 (4)† 18 (18) 0.2 0.09 1 (4)† 0 (0)† – 0.70 
Nausea 15 (60)† 49 (49)† 1.5 0.35 12 (44)† 3 (75)† 0.3 0.25 
Vomiting 15 (60)† 53 (54)‡ 1.3 0.60 10 (37)† 4 (100)† – 0.02 
Upper Respiratory Tract Sx 11 (44) 46 (47) 0.9 0.76 8 (33)‡ 1 (20)† 2.0 0.56 
     URI Symptoms* 4 (17)† 19 (19)† 0.9 0.84 4 (15)† 0 (0)† – 0.35 
     Allergies* 5 (22)† 24 (24)† 0.9 0.80 4 (15)† 1 (20)† 0.7 0.80 
     Nasal Congestion* 9 (35) 29 (30)‡ 1.2 0.67 6 (24)† 1 (17) 1.6 0.70 
No Effortful Activity 24 (96)† 85 (85)† 4.2 0.14 26 (93) 5 (83) 2.6 0.46 
 
* indicates that these symptoms were present the 2 weeks before initial presentation to physician 
for symptoms consistent with hemorrhagic stroke 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table G: Features Associated with Delayed Diagnosis According to Type of Initial Contact 
 
 Presented to Hospital Presented to Office/by Telephone  
Diagnostic Features Delayed Prompt Odds 
Ratio 
P-
value  
Delayed Prompt Odds 
Ratio 
P-
value  
 N = 26 
n (%) 
N = 102 
n (%) 
  N = 28 
n (%) 
N = 6 
n (%) 
  
         
Stroke Type: ICH 11 (42) 40 (39) 1.1 0.77 13 (46) 1 (17) 4.3 0.18 
 
* indicates that these symptoms were present the 2 weeks before initial presentation to physician 
for symptoms consistent with hemorrhagic stroke 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table H: Features Associated with Delayed Diagnosis of Subarachnoid Hemorrhage 
 
 
 SAH 
Demographic and Historical 
Features 
Delayed Prompt Odds Ratio P-value  
 N = 30 
n (%) 
N = 67 
n (%) 
  
     
Age < 40 Years 12 (40) 23 (34) 1.3 0.59 
Race     
     Caucasian 24 (80) 58 (87) 0.6 0.41 
     Black 5 (17) 9 (13) 1.3 0.68 
     Hispanic 4 (13) 5 (7) 1.9 0.36 
Female 10 (33) 41 (61) 0.3 0.01 
History of Migraine Diagnosis 4 (14)† 10 (15)† 0.9 0.91 
No Hypertension History 19 (63) 42 (63) 1.0 0.95 
Not Currently a Smoker 13 (43) 28 (42) 1.1 0.89 
No Primary Family History 30 (100) 63 (94) – 0.17 
No College Education 16 (53) 43 (64) 0.6 0.31 
Not Insured 5 (17) 11 (16) 1.0 0.98 
 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
 
 
 
 
 
  
72 
 
 
 
Table H: Features Associated with Delayed Diagnosis of Subarachnoid Hemorrhage 
 
 SAH 
Symptom Features Delayed Prompt Odds Ratio P-value  
 N = 30 
n (%) 
N = 67 
n (%) 
  
     
No Alarm Symptoms 18 (60) 22 (33)† 3.0 0.01 
     No Photophobia 25 (83) 43 (64) 2.8 0.06 
     No Loss of Consciousness 26 (87) 53 (82)† 1.5 0.53 
     No Focal Neurological Sx 25 (83) 55 (82) 1.1 0.88 
No Facial Pain 29 (97) 65 (97) 0.9 0.93 
No Neck Pain 17 (57) 21 (31) 2.9 0.02 
No Headache Present 1 (3)† 3 (5)† 0.7 0.80 
Nausea 16 (55)† 42 (66)† 0.6 0.34 
Vomiting 15 (52)† 44 (70)‡ 0.5 0.09 
Upper Respiratory Tract Sx 9 (33)† 34 (52)† 0.5 0.11 
     URI Symptoms (in 2 weeks) 2 (7)† 15 (23)† 0.3 0.07 
     Allergies (in 2 weeks) 6 (21)† 16 (25)† 0.8 0.74 
     Nasal Congestion (in 2 weeks) 8 (30)† 21 (32)† 0.9 0.80 
No Effortful Activity 28 (97)† 53 (80)† 6.9 0.04 
 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table H: Features Associated with Delayed Diagnosis of Subarachnoid Hemorrhage 
 
 SAH 
Diagnostic Features Delayed Prompt Odds Ratio P-value  
 N = 30 
n (%) 
N = 67 
n (%) 
  
     
Location of Evaluation: 
Office or Telephone 
15 (50) 5 (7) 12.4 <.0001 
 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table I: Features Associated with Delayed Diagnosis of Intracerebral Hemorrhage 
 
 
 ICH 
Demographic and Historical 
Features 
Delayed Prompt Odds Ratio P-value  
 N = 24 
n (%) 
N = 41 
n (%) 
  
     
Age < 40 Years 12 (50) 8 (20) 4.1 0.01 
Race     
     Caucasian 19 (79) 27 (66) 2.0 0.25 
     Black 3 (13) 12 (29) 0.3 0.12 
     Hispanic 4 (17) 3 (7) 2.5 0.24 
Female 17 (71) 16 (39) 3.8 0.01 
History of Migraine Diagnosis 6 (25) 5 (12) 2.4 0.18 
No Hypertension History 19 (79) 16 (39) 5.9 0.002 
Not Currently a Smoker 12 (50) 26 (63) 0.6 0.29 
No Primary Family History 21 (88) 38 (93) 0.6 0.56 
No College Education 11 (46) 28 (68) 0.4 0.07 
Not Insured 4 (17)† 4 (10)† 1.9 0.40 
 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table I: Features Associated with Delayed Diagnosis of Intracerebral Hemorrhage 
 
 ICH 
Symptom Features Delayed Prompt Odds Ratio P-value  
 N = 24 
n (%) 
N = 41 
n (%) 
  
     
No Alarm Symptoms 16 (67) 4 (10) 18.5 <.0001 
     No Photophobia 20 (83) 36 (90)† 0.6 0.44 
     No Loss of Consciousness 24 (100) 32 (80)†  0.02 
     No Focal Weakness 20 (83) 8 (20) 20.6 <.0001 
No Facial Pain 24 (100) 40 (98) – 0.44 
No Neck Pain 18 (75) 36 (88) 0.4 0.18 
No Headache Present 1 (4)† 15 (37) 0.1 0.004 
Nausea 11 (48)† 10 (26)† 2.7 0.07 
Vomiting 10 (43)† 13 (33)† 1.5 0.42 
Upper Respiratory Tract Sxs 10 (45)† 13 (36)‡ 1.5 0.48 
     URI Symptoms (in 2 weeks) 6 (29)† 4 (10)† 3.5 0.07 
     Allergies (in 2 weeks) 3 (14)† 9 (23)† 0.6 0.42 
     Nasal Congestion (in 2 wks) 7 (29) 9 (24)‡ 1.3 0.67 
No Effortful Activity 22 (92) 37 (93)† 0.9 0.90 
 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table I: Features Associated with Delayed Diagnosis of Intracerebral Hemorrhage 
 
 
 ICH 
Diagnostic Features Delayed Prompt Odds Ratio P-value  
 N = 24 
n (%) 
N = 41 
n (%) 
  
     
Location of Evaluation: 
Office or Telephone 
13 (54) 1 (2) 47.3 <.0001 
 
† indicates that there are 1-3 subjects missing from the stated n 
‡ indicates that there are 4-6 subjects missing from the stated n 
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Table J: Comparison of Percentage of Patients and Control Subjects According to 
Type of Initial Contact 
 
 
Demographic and 
Historical Features 
Presented to Hospital Presented to Office 
or by Telephone 
 N = 128 
n (%) 
N = 34 
n (%) 
   
Age < 40 Years 38 (30) 17 (50) 
Race   
     Caucasian 99 (77) 29 (85) 
     Black 27 (21) 2 (6) 
     Hispanic 14 (11) 2 (6) 
Female 68 (53) 16 (47) 
History of Migraine Dx 19 (15) 6 (18) 
No Hypertension History 72 (56) 24 (71) 
Not Currently a Smoker 67 (52) 12 (35) 
No Primary Family History 120 (95) 32 (94) 
No College Education 83 (65) 15 (44) 
Not Insured 20 (16) 4 (12) 
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Table J: Comparison of Percentage of Patients and Control Subjects According to 
Type of Initial Contact 
 
 
Symptom Features Presented to Hospital Presented to Office 
or by Telephone 
 N = 128 
n (%) 
N = 34 
n (%) 
   
No Alarm Symptoms 37 (29) 23 (68) 
     No Photophobia 96 (76) 28 (82) 
     No Loss of 
Consciousness 
102 (82) 33 (97) 
     No Focal Weakness 79 (62) 29 (85) 
No Facial Pain 124 (97) 34 (100) 
No Neck Pain 74 (58) 18 (53) 
No Headache Present 19 (15) 1 (3) 
Nausea 64 (52) 15 (48) 
Vomiting 68 (55) 14 (46) 
Upper Respiratory Tract Sx 57 (47) 9 (31) 
     URI Symptoms* 23 (19) 4 (13) 
     Allergies* 29 (24) 5 (16) 
     Nasal Congestion* 38 (31) 7 (23) 
No Effortful Activity 109 (87) 31 (91) 
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Table J: Comparison of Percentage of Patients and Control Subjects According to 
Type of Initial Contact 
 
 
 
Diagnostic Features Presented to Hospital Presented to Office 
or by Telephone 
 N = 128 
n(%) 
N = 34 
n (%) 
   
Stroke Type: ICH 51 (40) 14 (41) 
 
 
